MedTrace Logo

Vascular Access Outcome Measure for Function: a vaLidation Study In haemoDialysis

NCT03969225 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 702

Last updated 2024-05-10

No results posted yet for this study

Summary

A functioning vascular access provides a lifeline for patients requiring haemodialysis but vascular access dysfunction remains one of the leading causes of excessive morbidity, mortality and healthcare costs in this group. Despite increasing numbers of vascular access trials, successful interventions to improve vascular access function have been sparse and compromised by highly variable, often selectively reported outcome measures of limited relevance to patients and health professionals. Through engagement of all relevant stakeholders including patients and caregivers, vascular access function, defined by the need for interventions to enable and maintain the use of a vascular access for haemodialysis, has been identified as one of the most critically important outcome measures for trials in haemodialysis. This prospective, multi-centre, multinational validation study aims to assess the accuracy and feasibility of measuring vascular access function part of routine clinical practice and across different clinical settings to ensure successful global implementation of this core outcome measure in future trials in haemodialysis.

Conditions

  • Vascular Access Complication
  • Hemodialysis Access Failure (Disorder)

Sponsors & Collaborators

  • Australasian Kidney Trials Network

    collaborator NETWORK

  • The University of Queensland

    lead OTHER

Principal Investigators

  • Andrea Viecelli, MD, FRAC · Princess Alexandra Hospital and Australasian Kidney Trials Network

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-06
Primary Completion
2022-10-30
Completion
2023-02-17

Countries

  • Australia
  • Canada
  • France
  • Malaysia
  • Netherlands
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03969225 on ClinicalTrials.gov